Biomarker ID | 1200 |
PMID | 23935962 |
Year | 2013 |
Biomarker | miR-141 |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in PCa [Cohort 1: 27.9 fold; Cohort 2: 5.1 fold] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:- regulation of RNA metabolic process; Gene expression (Transcription); RNA Polymerase II Transcription; nuclear chromosome; DNA-binding transcription factor activity, RNA polymerase II-specific |
Experiment | Controls Vs Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Type of Biomarker | Diagnostic |
Cohort | Cohort 1: mCRPC patients (n=25) Vs age matched controls (n = 25);Cohort 2: 21 mCRPC patients and 20 age-matched healthy controls collected at the University of Michigan. |
Senstivity | NA |
Specificity | NA |
AUC | Cohort 1: 0.899; Cohort 2: 0.842 |
Accuracy | NA |
Level Of Significance | Training: p<0.0001; Testing: p<0.001 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | miR-141 |